Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 647-657

  Hsu, John T A ^a,b   Yeh, Jiann Yih ^a   Lin, Ta Jen ^c   Li, Mei Ling ^d   Wu, Ming Sian ^c   Hsieh, Chung Fan ^c   Chou, Yao Chieh ^c   Tang, Wen Fang ^c   Lau, Kean Seng ^c   Hung, Hui Chen ^a   Fang, Ming Yu ^a   Ko, Shengkai ^a   Hsieh, Hsing Pang ^a   Horng, Jim Tong ^c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; 6 BROMO 2 [1 (2,5 DIMETHYLPHENYL) 5 METHYL 1H PYRAZOL 4 YL] QUINOLINE 4 CARBOXYLIC ACID; AMANTADINE; ANTIVIRUS AGENT; BPR 3P0128; COMPLEMENTARY RNA; MESSENGER RNA; PRIMER RNA; RIBONUCLEASE; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOG; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; ENTEROVIRUS 71; ENZYME ACTIVITY; GENE SWITCHING; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; IC 50; INFLUENZA VIRUS A; INFLUENZA VIRUS B; KIDNEY CELL; MOLECULAR LIBRARY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA BINDING; RNA REPLICATION; RNA TRANSCRIPTION; VIRUS ATTACHMENT; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; ENDONUCLEASES; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE; PYRAZOLES; QUINOLINES; RNA CAPS; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84862908885     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00125-11     Document Type: Article

References (63)

1. Baba M, et al. 1998. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives. Mol. Pharmacol. 53:1097-1103. (Pubitemid 28280454)
2. Biswas SK, Boutz PL, Nayak DP. 1998. Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J. Virol. 72:5493-5501. (Pubitemid 28283331)
3. Blaas D, Patzelt E, Kuechler E. 1982. Identification of the cap binding protein of influenza virus. Nucleic Acids Res. 10:4803-4812.
4. Boulo S, Akarsu H, Ruigrok RW, Baudin F. 2007. Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res. 124:12-21. (Pubitemid 46216557)
5. Chase G, et al. 2008. Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology 377:431-439. (Pubitemid 351822379)
6. Cianci C, Tiley L, Krystal M. 1995. Differential activation of the influenza virus polymerase via template RNA binding. J. Virol. 69:3995-3999.
7. Conti C, et al. 1996. Inhibition of poliovirus replication by prostaglandins A and J. in human cells. Antimicrob. Agents Chemother. 40:367-372. (Pubitemid 26049349)
8. Coyne CB, et al. 2011. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 9:70-82.
9. Das K, Aramini JM, Ma LC, Krug RM, Arnold E. 2010. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol. 17:530-538.
10. Dawood FS, et al. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605-2615.
11. Dias A, et al. 2009. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458:914-918.
12. Ehrhardt C, Ludwig S. 2009. A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell. Microbiol. 11:863-871.
13. Fechter P, Brownlee GG. 2005. Recognition of mRNA cap structures by viral and cellular proteins. J. Gen. Virol. 86:1239-1249. (Pubitemid 40613240)
14. Fechter P, et al. 2003. Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J. Biol. Chem. 278:20381-20388. (Pubitemid 36799239)
15. Fislova T, Thomas B, Graef KM, Fodor E. 2010. Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT. J. Virol. 84:8691-8699.
16. Fodor E, et al. 2002. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J. Virol. 76:8989-9001. (Pubitemid 34919858)
17. Fodor E, Pritlove DC, Brownlee GG. 1994. The influenza virus panhandle is involved in the initiation of transcription. J. Virol. 68:4092-4096. (Pubitemid 24177444)
18. Francki RI, Jackson AO. 1972. Immunochemical detection of double-stranded ribonucleic acid in leaves of sugar cane infected with Fiji disease virus. Virology 48:275-277.
19. Furuta Y, et al. 2009. T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 82:95-102.
20. Gastaminza P, Perales B, Falcon AM, Ortin J. 2003. Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription. J. Virol. 77:5098-5108. (Pubitemid 36460924)
21. Geller R, Vignuzzi M, Andino R, Frydman J. 2007. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 21:195-205. (Pubitemid 46155813)
22. Guilligay D, et al. 2008. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 15:500-5066.
23. Hara K, Schmidt FI, Crow M, Brownlee GG. 2006. Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding. J. Virol. 80:7789-7798. (Pubitemid 44182280)
24. Hatada E, Hasegawa M, Mukaigawa J, Shimizu K, Fukuda R. 1989. Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J. Biochem. 105:537-546. (Pubitemid 19106773)
25. Henderson B. 2010. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem. Funct. 28:1-14.
26. Hirayama E, Atagi H, Hiraki A, Kim J. 2004. Heat shock protein 70 is related to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex. J. Virol. 78:1263-1270. (Pubitemid 38095836)
27. Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML. 2011. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 108:5777-5782.
28. Hsieh HP, Hsu JT. 2007. Strategies of development of antiviral agents directed against influenza virus replication. Curr. Pharm. Des. 13:3531-3542. (Pubitemid 350238942)
29. Huarte M, et al. 2003. Threonine 157 of influenza virus PA polymerase subunit modulates RNA replication in infectious viruses. J. Virol. 77: 6007-6013. (Pubitemid 36538991)
30. Kao RY, et al. 2010. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 28:600-605.
31. Kawakami E, et al. 2011. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173:1-6.
32. Layne SP, Monto AS, Taubenberger JK. 2009. Pandemic influenza: an inconvenient mutation. Science 323:1560-1561.
33. Li ML, Ramirez BC, Krug RM. 1998. RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA-binding sites. EMBO J. 17:5844-5852. (Pubitemid 28445995)
34. Li ML, Rao P, Krug RM. 2001. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J. 20:2078-2086. (Pubitemid 32397409)
35. Medcalf L, Poole E, Elton D, Digard P. 1999. Temperature-sensitive lesions in two influenza A viruses defective for replicative transcription disrupt RNA binding by the nucleoprotein. J. Virol. 73:7349-7356. (Pubitemid 29383218)
36. Mena I, et al. 1999. Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication. J. Virol. 73:1186-1194. (Pubitemid 29036770)
37. Momose F, et al. 2002. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J. Biol. Chem. 277:45306-45314. (Pubitemid 36159137)
38. Mullin AE, Dalton RM, Amorim MJ, Elton D, Digard P. 2004. Increased amounts of the influenza virus nucleoprotein do not promote higher levels of viral genome replication. J. Gen. Virol. 85:3689-3698. (Pubitemid 39591876)
39. Naito T, Momose F, Kawaguchi A, Nagata K. 2007. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J. Virol. 81:1339-1349. (Pubitemid 46167855)
40. Newcomb LL, et al. 2009. Interaction of the influenza A virus nucleocapsid protein with the viral RNA polymerase potentiates unprimed viral RNA replication. J. Virol. 83:29-36.
41. Okamoto H, et al. 2000. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37. Virology 272:402-408. (Pubitemid 30480200)
42. Ozawa M, et al. 2007. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J. Virol. 81:30-41. (Pubitemid 44975144)
43. Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1647-1689. In D. M. Knipe and P. M. Howley (ed), Fields virology, 5th ed, vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
44. Perez JT, et al. 2010. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl. Acad. Sci. U. S. A. 107:11525-11530.
45. Plotch SJ, Bouloy M, Ulmanen I, Krug RM. 1981. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23:847-858. (Pubitemid 11156997)
46. Portela A, Digard P. 2002. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83:723-734. (Pubitemid 34284855)
47. Porter JR, Fritz CC, Depew KM. 2010. Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy. Curr. Opin. Chem. Biol. 14:412-420.
48. Robb NC, Smith M, Vreede FT, Fodor E. 2009. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J. Gen. Virol. 90:1398-1407.
49. Ruigrok RW, Crepin T, Hart DJ, Cusack S. 2010. Towards an atomic resolution understanding of the influenza virus replication machinery. Curr. Opin. Struct. Biol. 20:104-113.
50. Schonborn J, et al. 1991. Monoclonal antibodies to double-stranded RNA as probes of RNA structure in crude nucleic acid extracts. Nucleic Acids Res. 19:2993-3000. (Pubitemid 21896939)
51. Scull MA, Rice CM. 2010. A big role for small RNAs in influenza virus replication. Proc. Natl. Acad. Sci. U. S. A. 107:11153-11154.
52. Shih SR, et al. 2010. Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J. Biomed. Sci. 17:13.
53. Shih SR, et al. 2010. BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. J. Antimicrob. Chemother. 65:63-71.
54. Tomassini JE, et al. 1996. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob. Agents Chemother. 40:1189-1193. (Pubitemid 26141396)
55. Ulmanen I, Broni BA, Krug RM. 1981. Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc. Natl. Acad. Sci. U. S. A. 78:7355-7359. (Pubitemid 12186139)
56. Vreede FT, Jung TE, Brownlee GG. 2004. Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates. J. Virol. 78:9568-9572. (Pubitemid 39096565)
57. Watanabe T, Watanabe S, Kawaoka Y. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427-439.
58. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:5059-5064.
59. Webster RG, Govorkova EA. 2006. H5N1 influenza - continuing evolution and spread. N. Engl. J. Med. 355:2174-2177. (Pubitemid 44791158)
60. Wise HM, et al. 2009. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83:8021-8031.
61. Wong WR, Chen YY, Yang SM, Chen YL, Horng JT. 2005. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 78:82-90.
62. Yeh JY, et al. 2010. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives. J. Med. Chem. 53:1519-1533.
63. Yuan P, et al. 2009. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 458:909-913.